Japan· JP-3923400A1010
ジメルカプロール
A dimercaprol product containing ジメルカプロール, registered in Japan, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Dimercaprol is registered in 4 of 19 countries.
Countries holding a registration under ATC V03AB09 (dimercaprol), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 2 of them publish a price we can compare per daily dose
Dimercaprol · ATC V03AB09
4 / 19 countries
- Finlandprice
- Japan
- Norwayprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ジメルカプロール
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- V03AB09
- ATC class
- Dimercaprol
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
7 interactions on record for dimercaprol.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dimercaprol · interactions on record
7 records
- 7 severe
Most severe, free to view
- Sodium seleniteA12CE02severe
- Ferrous fumarateB03AA02severe
- Ferrous gluconateB03AA03severe
- Ferrous sulfateB03AA07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AB09
Dimercaprol, as other registers publish it.
- FinlandB.A.L.Boots Healthcare International
- NorwayDimavalHeyl
- NorwayDimavalHeyl
- United KingdomDimercaprol 100mg/2ml solution for injection ampoulesA A H Pharmaceuticals Ltd
- United KingdomDimercaprol 100mg/2ml solution for injection ampoulesAdvanz Pharma
- United KingdomDimercaprol 100mg/2ml solution for injection ampoulesAlliance Healthcare (Distribution) Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4682b03-a59a-462f-8143-f0952b245314 GET /v1/drugs/d4682b03-a59a-462f-8143-f0952b245314?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０％１ｍＬ１管",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "3923400A1010",
"category": "注射薬",
"price_yen": null,
"generic_name": "ジメルカプロール",
"product_name_jp": null,
"therapeutic_class": "3923",
"transitional_expiry": null
}See everything about dimercaprol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.